Oxycodone m/r generic launched in UK
21st September 2012
Oxycodone m/r generic launched in UK
Qdem Pharmaceuticals (Cambridge, UK) have launched generic oxycodone m/r (Longtec prolonged release) 5mg, 10mg, 20mg, 40mg and 80mg tablets. Supplies will come from Bard Pharmaceuticals, the production and supply chain business of Napp, and will be available through the usual wholesalers. The NHS cost and product range comparison with Oxycontin m/r (Napp) is:
Longtec (Qdem)
Tablets m/r 5mg, 10mg, 20mg, 40mg and 80mg, 28 days @ 1 tablet b.d.= £21, £21, £42, £85, and £170 respectively.
Oxycontin (Napp)
Tablets m/r 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 60mg, 80mg and 120mg, 28 days @ 1 tablet b.d. = £25, £25, £37, £50, £75, £100, £150, £200 and £300 respectively.
Note: The remains of the m/r tablet may appear in the patient’s faeces (‘ghost tablets’), as can also occur with Oxycontin and Targinact (oxycodone/naloxone combined m/r tablet). These are inert residues, and do not affect the efficacy of the products.
Recent news
- Palliative Care Formulary available via the Association for Palliative Medicine (APM)
- NICE draft guideline for cannabidiol for Dravet syndrome
- NICE draft guideline for cannabidiol for Lennox-Gastaut syndrome
- NICE draft guideline for Cannabis-based medicinal products
- EMA adopts a positive opinion for Epidyolex
- Updated BTS/SIGN asthma guideline published
- Joint position statement on the decision by WHO to withdraw guidance documents
- Neuropathic pain in adults: updated NICE guidance
- BETTER- B breathlessness survey- last chance to complete
- Safer management of controlled drugs
News archive
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000